BioSpace News Archive

Intra-Cellular Therapies, Inc. today announced the publication of the results from its lumateperone monotherapy Phase 3 clinical trial (ITI-007-404).

Dyne Therapeutics, Inc today announced that management is scheduled to present during Chardan’s Virtual 5th Annual Genetic Medicines Conference.

Preclinical neuroscience company Delix Therapeutics (the “Company”), today announced the closing of a $70 million Series A financing round.

Palatin Technologies, Inc. announced the presentation of the protective effects of melanocortin 1 receptor agonists PL8331 and PL9654 in mouse models of retinopathy, at the 2021 Annual Meeting of the American Society of Retina Specialists (ASRS), being held virtually October 8-12, 2021.

Live fireside chat with Dr. Christopher J. Schaber, President and Chief Executive Officer of Soligenix on Wednesday, September 29 at 8:00 AM ET

Zebra Medical Vision announces today its eighth FDA 510(k) clearance for its cardiac solution, “HealthCCSng” which has already received a CE mark.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, announced today that David Arthur, Chief Executive Officer, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September 29-30, 2021.

Applied Genetic Technologies Corporation today announced that Sue Washer, President and Chief Executive Officer of AGTC, will be participating in a fireside chat at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference at 1:20 p.m.

Ortho Clinical Diagnostics, one of the world’s largest pure-play in vitro diagnostics companies, announced the availability of Immediate Spin Crossmatch on the company’s ORTHO VISION® and ORTHO VISION® MAX Analyzers to aid in detecting incompatibility between donors and recipients in blood transfusions.

Vaxart, Inc. (NASDAQ: VXRT), today announced the appointment of James F. Cummings, M.D., as the Company’s Chief Medical Officer (CMO). Dr. Cummings is a Board-Certified Infectious Diseases Physician with extensive experience in vaccine, drug and diagnostics development.